Discussion
I still remember what happened in 2022 after my mother received her myeloma diagnosis. I was sitting by her side in the hospital room.
Myeloma is a rare blood cancer that begins in plasma cells, a type of white blood cell normally responsible for producing antibodies that help fight off infectious pathogens and other threats.
While myeloma treatment can drive the disease into remission, sometimes for long periods of time, the cancer will often come back after a few months or years, and additional treatments will be needed.
Discussion
I still remember what happened in 2022 after my mother received her myeloma diagnosis. I was sitting by her side in the hospital room.
Most people with hard-to-treat multiple myeloma who were given a combination treatment of Talvey (talquetamab-tgvs) and Tecvayli (teclistamab-cqyv) in a clinical trial were alive…
Discussion
“Nobody is reading any of those essays you caregivers write,” a healthcare provider once told me. The following week, a stranger emailed me: “Your…
One-third of patients with hard-to-treat myeloma were alive and free from disease progression five years after a single infusion of the cell therapy Carvykti…
Discussion
When I recently read that former U.S. President Joe Biden had been diagnosed with prostate cancer and it had spread to his bones, my heart…
A committee of the European Medicines Agency has recommended approving GSK’s Blenrep (belantamab mafodotin) in combination with other therapeutic agents to treat relapsed or refractory…
Don't have an account?
|
Already have an account?
Create your account by filling in the information below:
By creating an account, you are agreeing to the Privacy Policy and Terms of Service.